Results
21,218 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER |  ACADACADIA PHARMACEUTICALS INCOpen-market sale | SELL | $24K 1,097 sh | Mar 26, 2026 traded Mar 26, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $24K 1,097 sh | Mar 26, 2026 traded Mar 26, 2026 | |
Choudary Kiran KumarChief Financial Officer |
 RBRKRubrik, Inc.Open-market sale |
| SELL |
| $5.91M 122.6K sh |
| Mar 26, 2026 traded Mar 24, 2026 |
| 32 | Li Jeffrey KSVP and Secretary |  KEYSKeysight Technologies, Inc.Open-market sale | SELL | $594K 2,000 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 32 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $804 37 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $18K 833 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 32 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale | SELL | $261 12 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 31 | Halter Timothy PDirector |  DXPEDXP ENTERPRISES INCOpen-market sale | SELL | $698K 5,000 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 31 | Flores JessicaExecutive VP & CAO |  SBRASabra Health Care REIT, Inc.Open-market sale | SELL | $302K 15.2K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 31 | Zitkus LesterSVP, Land |  GPORGULFPORT ENERGY CORPOpen-market sale | SELL | $401K 1,873 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 30 | Balcom AlexandraChief Financial Officer |  NUVLNuvalent, Inc.Open-market sale · 10b5-1 plan | SELL | $735K 7,671 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 29 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $1.37M 13.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 29 | Tonnel David AChief Accounting Officer |  SMRNUSCALE POWER CorpOpen-market sale | SELL | $27K 2,290 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 28 | Morais Silvio JoseDirector |  STNEStoneCo Ltd.Open-market sale | SELL | $97K 6,800 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 28 | Dhanasekaran SatishDirector, President and CEO | KEYSKeysight Technologies, Inc. Open-market sale | SELL | $500K 1,667 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 28 | Murphy Matthew JDirector, Chairman of the Board and CEO |  MRVLMarvell Technology, Inc.Open-market sale · 10b5-1 plan | SELL | $2.96M 30.0K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 25 | Owens Bradley D.General Counsel |  ZANDZGZILLOW GROUP, INC.Open-market sale · 10b5-1 plan | SELL | $384K 8,800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 23 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $112K 1,160 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 23 | Balcom AlexandraChief Financial Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $247K 2,599 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 22 | Rubinstein JuliePresident and COO |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $269K 19.1K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 22 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $272K 19.1K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 18 | Samuelson Errol GChief Industry Dev. Officer | ZANDZGZILLOW GROUP, INC. Open-market sale · 10b5-1 plan | SELL | $209K 4,734 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 16 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $261K 19.1K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 14 | Bowe Patrick E.Director |  ANDEAndersons, Inc.Open-market sale · 10b5-1 plan | SELL | $1.03M 14.2K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 14 | Ugwumba Chidozie10% Owner |  CLNNClene Inc.Open-market sale | SELL | $29K 5,319 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 14 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $32K 5,492 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 14 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $39K 7,098 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 11 | Colendich Katie MarieGC, Corporate Secretary |  ASANAsana, Inc.Open-market sale · 10b5-1 plan | SELL | $32K 5,015 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 11 | Werner Edward CooperChief Financial Officer |  FFIVF5, INC.Open-market sale · 10b5-1 plan | SELL | $300K 1,000 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 11 | Colendich Katie MarieGC, Corporate Secretary | ASANAsana, Inc. Open-market sale · 10b5-1 plan | SELL | $9,585 1,500 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 8 | Raben DavidChief Medical Officer |  BCAXBicara Therapeutics Inc.Open-market sale · 10b5-1 plan | SELL | $104K 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 8 | Low RussellDirector, PRESIDENT AND CEO |  ACLSAXCELIS TECHNOLOGIES INCOpen-market sale · 10b5-1 plan | SELL | $112K 1,244 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 8 | Bowe Patrick E.Director | ANDEAndersons, Inc. Open-market sale · 10b5-1 plan | SELL | $58K 800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 4 | Misra AmitabhChief Technology Officer |  CXMSprinklr, Inc.Open-market sale · 10b5-1 plan | SELL | $243K 41.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 44 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $1.03M 12.6K sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $634K 7,749 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $431K 5,140 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $634K 7,749 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $265K 3,162 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $265K 3,162 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 38 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $131K 1,541 sh | Mar 25, 2026 traded Mar 23, 2026 |